Q3695257 (Q3695257): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): Over the coming decades, our health and care system will face significant financial constraints due to the growing increase in cancers; innovative low-cost treatments can be designed to cope with them., translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
Over the coming decades, our health and care system will face significant financial constraints due to the growing increase in cancers; innovative low-cost treatments can be designed to cope with them. (English) | |||||||||||||||
| Property / summary: Over the coming decades, our health and care system will face significant financial constraints due to the growing increase in cancers; innovative low-cost treatments can be designed to cope with them. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Over the coming decades, our health and care system will face significant financial constraints due to the growing increase in cancers; innovative low-cost treatments can be designed to cope with them. (English) / qualifier | |||||||||||||||
point in time: 18 November 2021
| |||||||||||||||
Revision as of 19:04, 18 November 2021
Project Q3695257 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3695257 in France |
Statements
47,500.0 Euro
0 references
109,593.66 Euro
0 references
43.34 percent
0 references
18 March 2016
0 references
31 October 2018
0 references
Université de Bourgogne
0 references
Au cours des prochaines décennies, notre système de soins et de santé sera confronté à d’importantes contraintes financières en raison de la hausse croissante des cancers; des traitements innovants à faible coût peuvent être conçus afin d'y faire face. (French)
0 references
Over the coming decades, our health and care system will face significant financial constraints due to the growing increase in cancers; innovative low-cost treatments can be designed to cope with them. (English)
18 November 2021
0 references
Identifiers
BG0005826
0 references